/Argenta%20Logo.png?width=128&height=54&name=Argenta%20Logo.png "Argenta logo")
Download the eBook and fact sheet on
Microsphere technology for animal health products
eBook
Accelerating the path to market for microspheres
Conventional drug delivery systems can present challenges like limited bioavailability, uncontrolled active pharmaceutical ingredient (API) release, and administration difficulties. As a promising alternative, controlled-release microspheres offer advantages over traditional methods but pose unique development and market-entry challenges. Overcoming these can lead to innovative products or extend the lifecycle of existing treatments.
Download our insight-packed microspheres eBook and discover:
- What microspheres are
- How they can help you sidestep some of the toughest drug delivery challenges
- The key pitfalls at each stage of the microspheres development and manufacturing process
- How you can overcome them to carve out a de-risked, faster, and more cost-effective path to market
Fact sheet
Argenta microspheres for animal health products
Argenta's technology comprises amorphous or crystalline API dispersed throughout a biodegradable wax matrix.
Unlike other microsphere technologies, Argenta's microspheres don’t use organic solvents during manufacturing, don’t require excessively high manufacturing temperatures that could degrade many APIs and typically use only 1–2 excipients, which are more cost-effective than other commonly used biocompatible polymers.
Download our fact sheet to learn more about:
- Key specifications of Argenta’s licensable microspheres technology
- The range of APIs, administration routes, species, and indications for which our microspheres are suitable
- How Argenta can help speed the path from 'molecule to market' for microspheres-based therapies
Argenta delivers high-quality products and services to our global animal health and nutrition partners. Our unique 'molecule to market' approach means that we can partner comprehensively across a product's complete development cycle or step in where we add the most value — from concept to commercialisation.